| Title | Author(s) | Issue date | ???itemlist.??? |
| Alterations in uric acid serum levels in laparoscopic procedures of upper abdomen | Glantzounis, G. K.; Tsimaris, I.; Vasakos, S.; Tambaki, A. P.; Tselepis, A. D.; Galaris, D.; Tsimoyiannis, E. C. | 24-Nov-2015 | - |
| Altered distribution of platelet-activating factor- acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia | Tsimihodimos, V.; Karabina, S. A.; Tambaki, A. P.; Bairaktari, E.; Miltiadous, G.; Goudevenos, J. A.; Cariolou, M. A.; Chapman, M. J.; Tselepis, A. D.; Elisaf, M. S. | 24-Nov-2015 | - |
| Altered distribution of platelet-activating factor-acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia | Tsimihodimos, V.; Karabina, S. A. P.; Tambaki, A. P.; Bairaktari, E.; Miltiadous, G.; Goudevenos, J. A.; Cariolou, M. A.; Chapman, M. J.; Tselepis, A. D.; Elisaf, M. | 24-Nov-2015 | - |
| Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB | Tsimihodimos, V.; Karabina, S. A. P.; Tambaki, A. P.; Bairaktari, E.; Goudevenos, J. A.; Chapman, M. J.; Elisaf, M.; Tselepis, A. D. | 24-Nov-2015 | - |
| Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB | Tsimihodimos, V.; Karabina, S. A.; Tambaki, A. P.; Bairaktari, E.; Goudevenos, J. A.; Chapman, M. J.; Elisaf, M. S.; Tselepis, A. D. | 24-Nov-2015 | - |
| Differential effect of hypolipidemic drugs on lipoprotein-associated phospholipase A(2) | Saougos, V. G.; Tambaki, A. P.; Kalogirou, M.; Kostapanos, M.; Gazi, I. F.; Wolfert, R. L.; Elisaf, M.; Tselepis, A. D. | 24-Nov-2015 | - |
| Effect of synthetic peptides corresponding to residues 313-332 of the alpha(IIb) subunit on platelet activation and fibrinogen binding to alpha(IIb)beta(3) | Mitsios, J. V.; Tambaki, A. P.; Abatzis, M.; Biris, N.; Sakarellos-Daitsiotis, M.; Sakarellos, C.; Soteriadou, K.; Goudevenos, J.; Elisaf, M.; Tsoukatos, D.; Tsikaris, V.; Tselepis, A. D. | 24-Nov-2015 | - |
| Effects of antihypertensive and hypolipidemic drugs on plasma and high-density lipoprotein-associated platelet activating factor-acetylhydrolase activity | Tambaki, A. P.; Rizos, E.; Tsimihodimos, V.; Tselepis, A. D.; Elisaf, M. | 24-Nov-2015 | - |
| Fenofibrate induces HDL-associated PAF-AH but attenuates enzyme activity associated with apoB-containing lipoproteins | Tsimihodimos, V.; Kakafika, A.; Tambaki, A. P.; Bairaktari, E.; Chapman, M. J.; Elisaf, M.; Tselepis, A. D. | 24-Nov-2015 | - |
| Lack of effect of acute repaglinide administration on postprandial lipaemia in patients with type 2 diabetes mellitus | Tentolouris, N.; Kolia, M.; Tselepis, A. D.; Perea, D.; Kitsou, E.; Kyriaki, D.; Tambaki, A. P.; Karabina, S. P.; Sala, C.; Fragoulopoulos, E.; Katsilambros, N. | 24-Nov-2015 | - |
| Laparoscopic surgery-induced changes in oxidative stress markers in human plasma | Glantzounis, G. K.; Tselepis, A. D.; Tambaki, A. P.; Trikalinos, T. A.; Manataki, A. D.; Galaris, D. A.; Tsimoyiannis, E. C.; Kappas, A. M. | 24-Nov-2015 | - |
| Lipoprotein-associated PAF-acetylhydrolase activity in subjects with the metabolic syndrome | Rizos, E.; Tambaki, A. P.; Gazi, I.; Tselepis, A. D.; Elisaf, M. | 24-Nov-2015 | - |
| Platelet aggregatory response to platelet activating factor (PAF), ex vivo, and PAF-acetylhydrolase activity in patients with unstable angina: effect of c7E3 Fab (abciximab) therapy | Tselepis, A. D.; Goudevenos, J. A.; Tambaki, A. P.; Michalis, L.; Stroumbis, C. S.; Tsoukatos, D. C.; Elisaf, M.; Sideris, D. A. | 24-Nov-2015 | - |
| Platelet hyperaggregability to platelet activating factor (PAF) in non-ST elevation acute coronary syndromes | Michalis, L. K.; Tambaki, A. P.; Katsouras, C. S.; Goudevenos, J. A.; Kolettis, T.; Adamidis, K.; Tselepis, A. D.; Sideris, D. A. | 24-Nov-2015 | - |
| The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activity | Kakafika, A. I.; Xenofontos, S.; Tsimihodimos, V.; Tambaki, A. P.; Lourida, E. S.; Kalaitzidis, R.; Cariolou, M. A.; Elisaf, M.; Tselepis, A. D. | 24-Nov-2015 | - |
| Repaglinide reduces postprandial chylomicron-deficient plasma triglycerides in patients with type 2 diabetes | Tentolouris, N.; Kolia, M.; Tselepis, A. D.; Perea, D.; Kitsou, E.; Alevizou, V.; Tambaki, A. P.; Karabina, S. A. P.; Sala, C.; Fragoulopoulos, V.; Katsilambros, N. | 24-Nov-2015 | - |
| Serum lipoprotein(a) concentrations and apolipoprotein(a) isoforms: association with the severity of clinical presentation in patients with coronary heart disease | Katsouras, C. S.; Karabina, S. A.; Tambaki, A. P.; Goudevenos, J. A.; Michalis, L. K.; Tsironis, L. D.; Stroumbis, C. S.; Elisaf, M. S.; Sideris, D. A.; Tselepis, A. D. | 24-Nov-2015 | - |
| Thyroid substitution therapy induces high-density lipoprotein-associated platelet-activating factor-acetylhydrolase in patients with subclinical hypothyroidism: a potential antiatherogenic effect | Milionis, H. J.; Tambaki, A. P.; Kanioglou, C. N.; Elisaf, M. S.; Tselepis, A. D.; Tsatsoulis, A. | 24-Nov-2015 | - |
